Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-036832
Filing Date
2025-03-11
Accepted
2025-03-11 07:45:40
Documents
15
Effectiveness Date
2025-03-11

Document Format Files

Seq Description Document Type Size
1 S-8 rapp-20250311.htm S-8 96462
2 EX-5.1 rapp-ex5_1.htm EX-5.1 12262
3 EX-23.1 rapp-ex23_1.htm EX-23.1 2769
4 EX-FILING FEES rapp_exfilingfees.htm   iXBRL EX-FILING FEES 43454
  Complete submission text file 0000950170-25-036832.txt   303465

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT rapp_exfilingfees_htm.xml XML 12507
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285697 | Film No.: 25725881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)